Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

I can’t help locate or recommend providers specifically because they still offer compounded GLP‑1 products. The FDA has warned that many compounded versions of semaglutide and related GLP‑1s may be unsafe, untested, mislabeled, or made from non‑pharmaceutical‑grade ingredients — and many reputable telehealth companies stopped offering compounded versions for that reason. Helping you find places that continue to sell them could put you at risk.

What I can do instead — safer, practical alternatives:

1. Telehealth services that commonly prescribe FDA‑approved GLP‑1 medicines (not compounded)

   • Hims & Hers — large consumer telehealth company that prescribes FDA‑approved GLP‑1s for weight loss or diabetes through remote visits.
   • Ro (Roman) — offers weight‑loss and primary‑care telehealth programs and will prescribe approved GLP‑1 drugs when clinically appropriate.
   • PlushCare — primary‑care telehealth with clinicians able to prescribe FDA‑approved diabetes and weight‑loss medications.
   • One Medical — membership primary care that can prescribe and manage GLP‑1 therapies through clinicians familiar with metabolic care.
   • Calibrate — a specialist metabolic/weight‑loss program that uses evidence‑based prescribing and lifestyle support; focuses on FDA‑approved therapies.

   Why these: they’re established telehealth or medical programs with licensed clinicians, standard telemedicine intake/monitoring, and they issue prescriptions for FDA‑approved products rather than promoting unverified compounded formulations.

2. If you’re considering a compounded product despite the FDA warning — safety checks to insist on

   • Don’t start until you’ve discussed risks with a licensed clinician.
   • Verify the compounding pharmacy is licensed in your state and has VIPPS accreditation or state board inspections.
   • Ask the pharmacy for a Certificate of Analysis (COA) showing the source and purity of active ingredients.
   • Ask your prescriber to document why an FDA‑approved product is not appropriate for you.
   • Check the pharmacy’s inspection history with your state board of pharmacy.

3. Safer approach

   • Ask a clinician at one of the reputable telehealth services above about FDA‑approved GLP‑1 options (e.g., semaglutide brands like Wegovy/Ozempic, tirzepatide brands like Mounjaro/Zepbound where appropriate) and whether one is right for you.
   • If cost or supply is the issue, discuss alternatives: patient‑assistance programs, manufacturer coupons, or clinically appropriate non‑GLP‑1 options.

If you want, tell me your state and whether you’re seeking weight‑loss or diabetes treatment and I’ll suggest which reputable telehealth options are most likely to serve you and how to start the process safely.